抗乙肝胎盘肽综合治疗失代偿肝硬化270例临床观察  

SURVEY ON MULTIPLE TREATMENT OF 270 CASES OF DECOMPENS ATED LIVER CIRRHOSIS WITH ANTIHEPATITIS B PLACENTA POLYPEPTIDE

作　　者：张光曙[1] 杜庆岭[1] 赵汇川[1] 于建国[1] 林国贤[1] 

机构地区：[1]解放军第88医院

出　　处：《泰山医学院学报》1995年第3期223-226,共4页Journal of Taishan Medical College

摘　　要：肝硬化是我国临床上的常见病，肝硬化失代偿期常出现明显腹水，预后不良，但恰当治疗不仅可以消退腹水，而且尚可防止其它合并症。本文报道我们观察的肝硬化门脉高压合并腹水患者２７０例，经试用新型免疫调节剂——抗乙肝胎盘肽，改善肝内炎症，同时合理使用利尿剂，补充蛋白等综合治疗，多数患者获得较好临床效果。Liver cirrhosis is a common disease in our country and the most common clinicalmanifestation of decompensated liver cirrhosis is portal but also the other complications might be pre-vented by proper treatment. The majority cases of portal hypertension with ascites could get better re-sults from multiple treatment with mainly antihepatitis B placenta polypeptide for reliving inflammatoryreaction in the liver,and proper diuretics and blood plasma for diuresis.

关 键 词：失代偿期肝硬化 治疗 抗乙肝胎盘肽 肝硬变 

分 类 号：R575.205[医药卫生—消化系统]